-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T04Ukph+5MpzlAnLgwtkB/f6j1LTLjMc3jcIVf7MJ0bFH/sxIkxbdg+j2Hjc6M4R UMaCEcwnWBv5okRlZMLSOQ== 0001266375-06-000040.txt : 20060302 0001266375-06-000040.hdr.sgml : 20060302 20060302115703 ACCESSION NUMBER: 0001266375-06-000040 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060301 FILED AS OF DATE: 20060302 DATE AS OF CHANGE: 20060302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROGENICS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000835887 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133379479 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9147892800 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ISRAEL ROBERT J CENTRAL INDEX KEY: 0001250274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23143 FILM NUMBER: 06658560 MAIL ADDRESS: STREET 1: 50 OXFORD DR CITY: MONTEBELLE STATE: NY ZIP: 10901 4 1 edgardoc.xml PRIMARY DOCUMENT X0202 4 2006-03-01 0 0000835887 PROGENICS PHARMACEUTICALS INC PGNX 0001250274 ISRAEL ROBERT J 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 Sr. VP, Medical Affairs Common Stock 2006-03-01 4 M 0 10000 4 A 30628 D Common Stock 2006-03-01 4 S 0 10000 29.021 D 20628 D Non-Qualified Stock Option (right to buy) 4 2006-03-01 4 M 0 10000 0 D 2002-03-31 2007-04-01 Common Stock 10000 55000 D Sale under a 10b5-1 Plan, which was established in accordance with the policies and procedures of the Issuer, approved by its Board of Directors The Reporting Person is exercising options under this grant in pre-established increments under and in accordance with provisions of a previously established Plan of Sale under Rule 10b5-1, which was established in accordance with the policies and procedures of the Issuer, approved by its Board of Directors. Robert J. Israel 2006-03-02 -----END PRIVACY-ENHANCED MESSAGE-----